Recurrent Variable Decelerations at 33 Weeks With Severe Preeclampsia
At 33+2 weeks, a nulliparous patient is admitted with preeclampsia with severe features: BP 168/112 mm Hg, platelets 92,000/µL, AST 88 U/L, creatinine 1.0 mg/dL, persistent headache, and visual scotomata. She is receiving magnesium sulfate 2 g/h. The cervix is 1 cm dilated and 50% effaced, with irregular contractions. External monitoring shows a baseline of 145 bpm, minimal variability (3–5 bpm) for 40 minutes, and recurrent variable decelerations to 65–75 bpm lasting 40–50 seconds with each contraction, returning to baseline. Ultrasound estimates fetal weight at 1,760 g, AFI 5.8 cm, and umbilical artery Doppler shows absent end-diastolic flow. The level III NICU is in-house; maternal-fetal medicine and the operating room are available. Betamethasone has not been given. The patient is afebrile; membranes are intact and there is no vaginal bleeding.
1. How would you categorize this fetal heart rate tracing, and what is your immediate bedside management?
Read the worked answer
This is a Category II tracing, not Category III: the variability is minimal rather than absent, and there are no recurrent late decelerations or a sinusoidal pattern. However, the combination of minimal variability, recurrent variable decelerations, absent umbilical artery end-diastolic flow, and severe maternal disease makes acidemia plausible. Immediate management is intrauterine resuscitation while preparing for delivery: reposition left lateral, give an IV crystalloid bolus, continue magnesium for seizure prophylaxis, and check maternal oxygenation and blood pressure. Amnioinfusion can be considered for recurrent variable decelerations with oligohydramnios, but it should not delay delivery when Doppler flow is absent and maternal features are severe. Do not give tocolytics. Give betamethasone only if delivery can be safely postponed; because the tracing is nonreassuring, the 48-hour window should not be prioritized over fetal status. Reassess the tracing every 5–10 minutes. If there is no improvement after 20–30 minutes, proceed to cesarean delivery for nonreassuring fetal status.
2. The tracing remains unchanged after 30 minutes. Outline the delivery plan and neonatal preparation.
Read the worked answer
Persistent minimal variability and recurrent decelerations after resuscitation justify cesarean delivery; the goal is to shorten the interval from decision to delivery. Notify NICU, anesthesia, and the blood bank. Anticipate a 1.8-kg preterm infant with RDS, hypoglycemia, hypothermia, thrombocytopenia, and possible magnesium-related hypotonia. Prepare a prewarmed resuscitation bed, CPAP or intubation equipment, surfactant, UVC supplies, and a glucose meter. Delayed cord clamping for 30–60 seconds is reasonable if the infant is vigorous, but not if resuscitation is needed. Obtain cord blood gas and complete blood count; do not start antibiotics solely for prematurity. Because maternal platelets are 92,000/µL, check the infant's platelet count and observe for bleeding. Communicate the maternal magnesium infusion to the resuscitation team, since it can cause respiratory depression and poor tone. Plan for early parenteral nutrition and minimal handling.
3. How does maternal magnesium sulfate influence neonatal assessment and management?
Read the worked answer
Magnesium sulfate crosses the placenta; the fetus may have hypotonia, respiratory depression, poor suck, and reduced heart rate variability. The minimal variability on the tracing may be partly a magnesium effect, but it does not explain recurrent variable decelerations or absent end-diastolic flow. In the delivery room, provide gentle stimulation and PPV if needed; do not give naloxone, because it reverses opioid, not magnesium, depression. Monitor respiratory effort, tone, feeding, and oxygen saturation for 24–48 hours. If there is marked hypotonia or apnea, check serum magnesium and calcium, and support ventilation. Magnesium toxicity in the newborn is managed supportively; calcium gluconate is not routinely indicated. Continue maternal magnesium because it prevents eclampsia. Document the exposure and inform the pediatric team.